Jeffrey Stein
2019
In 2019, Jeffrey Stein earned a total compensation of $1.5M as President and Chief Executive Officer at Cidara Therapeutics, a 6% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $268,300 |
|---|---|
| Option Awards | $480,869 |
| Salary | $526,000 |
| Stock Awards | $174,000 |
| Other | $2,800 |
| Total | $1,451,969 |
Stein received $526K in salary, accounting for 36% of the total pay in 2019.
Stein also received $268.3K in non-equity incentive plan, $480.9K in option awards, $174K in stock awards and $2.8K in other compensation.
Rankings
In 2019, Jeffrey Stein's compensation ranked 7,460th out of 13,971 executives tracked by ExecPay. In other words, Stein earned more than 46.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,460 out of 13,971 | 47th |
Division Manufacturing | 2,893 out of 5,701 | 49th |
Major group Chemicals And Allied Products | 1,085 out of 2,200 | 51st |
Industry group Drugs | 925 out of 1,886 | 51st |
Industry Biological Products, Except Diagnostic Substances | 217 out of 389 | 44th |
Source: SEC filing on April 29, 2020.
Stein's colleagues
We found two more compensation records of executives who worked with Jeffrey Stein at Cidara Therapeutics in 2019.
News
Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M
June 3, 2024
Cidara Therapeutics CEO Jeffrey Stein's 2022 pay falls 23% to $1.3M
April 27, 2023
Cidara Therapeutics CEO Jeffrey Stein's 2021 pay jumps 26% to $1.6M
April 29, 2022
Cidara Therapeutics CEO Jeffrey Stein's 2019 pay rises 6% to $1.5M
April 29, 2020
Cidara Therapeutics CEO Jeffrey Stein's 2018 pay falls 25% to $1.4M
April 26, 2019